 |
|
Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
Jong Won Seo, Eun Soo Kim, Man-Hoon Han, Young Oh Kweon
Intest Res. 2021;19(2):247-251. Published online 2020 Jul 2 DOI: https://doi.org/10.5217/ir.2020.00016
|
|
Citations to this article as recorded by
 Non-Cirrhotic Portal Hypertension: an Overview
Sajid Jalil, Ashwani K. Singal
Current Hepatology Reports.2024; 23(1): 153. CrossRef Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
Hye Kyung Hyun, Hye Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
Gut and Liver.2024; 18(2): 294. CrossRef A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
Michele Fiordaliso, Giuseppe Marincola, Barbara Pala, Raffaella Muraro, Mariangela Mazzone, Maria Carmela Di Marcantonio, Gabriella Mincione
Diagnostics.2023; 13(20): 3263. CrossRef Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review
Nicola Pugliese, Lucia Giuli, Elisabetta Mastrorocco, Francesco Santopaolo, Giacomo Marcozzi, Cristina Bezzio, Arianna Dal Buono, Roberto Gabbiadini, Antonio Gasbarrini, Francesca Romana Ponziani, Alessandro Armuzzi, Alessio Aghemo
Digestive and Liver Disease.2023;[Epub] CrossRef Nichtzirrhotische portale Hypertension – Ursachen und praktisches Management
A. Queck, J. Trebicka
Der Gastroenterologe.2021; 16(2): 90. CrossRef
|